Salvador Villa

Summary

Country: Spain

Publications

  1. doi request reprint Radiation and concomitant chemotherapy for patients with glioblastoma multiforme
    Salvador Villa
    Radiation Oncology, Catalan Institute of Oncology, HU Germans Trias, Badalona 08916, Catalonia, Spain
    Chin J Cancer 33:25-31. 2014
  2. doi request reprint Primary pineal tumors: outcome and prognostic factors--a study from the Rare Cancer Network (RCN)
    Salvador Villa
    Radiation Oncology, Catalan Institute of Oncology, H Universitari Germans Trías, Badalona, Barcelona, Catalonia, Spain
    Clin Transl Oncol 14:827-34. 2012
  3. pmc Quality assurance of radiotherapy in the ongoing EORTC 22042-26042 trial for atypical and malignant meningioma: results from the dummy runs and prospective individual case Reviews
    Mehtap Coskun
    Department of Radiation Oncology, Ankara Oncology Hospital, Ankara, Turkey
    Radiat Oncol 8:23. 2013
  4. pmc Validation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study
    Salvador Villa
    Department of Radiation Oncology and Clinical Epidemiology, Geneva University Hospital, Geneva, Switzerland
    Radiat Oncol 6:23. 2011
  5. pmc Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study
    Wendy Jeanneret-Sozzi
    Centre Hospitalier Universitaire Vaudois and University of Lausanne, Rue du Bugnon, CH 1011 Lausanne, Switzerland
    BMC Cancer 8:86. 2008
  6. doi request reprint Evolution of care for patients with relapsed glioblastoma
    Carmen Balañá
    Medical Oncology Service, Institut Catala d Oncologia, Germans Trias i Pujol, Carretera Canyet sn, 08916 Badalona, Barcelona, Spain
    Expert Rev Anticancer Ther 11:1719-29. 2011
  7. ncbi request reprint Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas
    Marta Brell
    Institut d Investigacio Biomedica de Bellvitge, Hospital Universitari de Bellvitge, Barcelona, Spain
    Clin Cancer Res 11:5167-74. 2005
  8. ncbi request reprint Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network
    Damien C Weber
    University Hospital of Geneva, Geneva, Switzerland
    Int J Radiat Oncol Biol Phys 66:179-86. 2006
  9. ncbi request reprint Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial
    Eugenia Verger
    Hospital Clinic and Institut d Investigació Biomèdica August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain
    Int J Radiat Oncol Biol Phys 61:185-91. 2005
  10. pmc The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer Network
    Brigitta G Baumert
    Radiation Oncology, University Hospital Zurich, Switzerland
    Radiat Oncol 2:12. 2007

Collaborators

Detail Information

Publications13

  1. doi request reprint Radiation and concomitant chemotherapy for patients with glioblastoma multiforme
    Salvador Villa
    Radiation Oncology, Catalan Institute of Oncology, HU Germans Trias, Badalona 08916, Catalonia, Spain
    Chin J Cancer 33:25-31. 2014
    ..Elderly patients with tumors that exhibit methylation of the O-6-methylguanine-DNA methyltransferase promoter can benefit from TMZ alone. ..
  2. doi request reprint Primary pineal tumors: outcome and prognostic factors--a study from the Rare Cancer Network (RCN)
    Salvador Villa
    Radiation Oncology, Catalan Institute of Oncology, H Universitari Germans Trías, Badalona, Barcelona, Catalonia, Spain
    Clin Transl Oncol 14:827-34. 2012
    ..To better define outcome and prognostic factors in primary pineal tumors...
  3. pmc Quality assurance of radiotherapy in the ongoing EORTC 22042-26042 trial for atypical and malignant meningioma: results from the dummy runs and prospective individual case Reviews
    Mehtap Coskun
    Department of Radiation Oncology, Ankara Oncology Hospital, Ankara, Turkey
    Radiat Oncol 8:23. 2013
    ..The results of the Dummy Run (DR) and prospective Individual Case Review (ICR) were analyzed in this Quality Assurance (QA) study...
  4. pmc Validation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study
    Salvador Villa
    Department of Radiation Oncology and Clinical Epidemiology, Geneva University Hospital, Geneva, Switzerland
    Radiat Oncol 6:23. 2011
    ..We evaluated the new Graded Prognostic Assessment (GPA) scale in a prospective validation study to compare it with two published prognostic indexes...
  5. pmc Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study
    Wendy Jeanneret-Sozzi
    Centre Hospitalier Universitaire Vaudois and University of Lausanne, Rue du Bugnon, CH 1011 Lausanne, Switzerland
    BMC Cancer 8:86. 2008
    ..To asses the clinical profile, treatment outcome and prognostic factors in primary breast lymphoma (PBL)...
  6. doi request reprint Evolution of care for patients with relapsed glioblastoma
    Carmen Balañá
    Medical Oncology Service, Institut Catala d Oncologia, Germans Trias i Pujol, Carretera Canyet sn, 08916 Badalona, Barcelona, Spain
    Expert Rev Anticancer Ther 11:1719-29. 2011
    ..Data from ongoing and planned trials should help to define optimal treatment strategies for this disease...
  7. ncbi request reprint Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas
    Marta Brell
    Institut d Investigacio Biomedica de Bellvitge, Hospital Universitari de Bellvitge, Barcelona, Spain
    Clin Cancer Res 11:5167-74. 2005
    ..The aim of this study was to evaluate the prognostic significance of MGMT in patients with anaplastic glioma...
  8. ncbi request reprint Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network
    Damien C Weber
    University Hospital of Geneva, Geneva, Switzerland
    Int J Radiat Oncol Biol Phys 66:179-86. 2006
    ..The aim of this study was to assess the outcome in patients with cerebellar glioblastoma (GBM) treated in 15 institutions of the Rare Cancer Network...
  9. ncbi request reprint Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial
    Eugenia Verger
    Hospital Clinic and Institut d Investigació Biomèdica August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain
    Int J Radiat Oncol Biol Phys 61:185-91. 2005
    ..To evaluate the safety profile and efficacy of whole brain radiotherapy (WBRT) concomitantly with temozolomide (TMZ) in patients with brain metastases (BM)...
  10. pmc The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer Network
    Brigitta G Baumert
    Radiation Oncology, University Hospital Zurich, Switzerland
    Radiat Oncol 2:12. 2007
    ..A multi-centre study to assess the value of combined surgical resection and radiotherapy for the treatment of desmoid tumours...
  11. doi request reprint Translational research in glioblastoma multiforme: molecular criteria for patient selection
    Rafael Rosell
    Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Ctra Canyet, S N, 08916 Barcelona, Spain
    Future Oncol 4:219-28. 2008
    ..Translational clinical trials are warranted in order to detect the subgroups of patients resistant to radiotherapy who may derive benefit from novel therapies, including antiangiogenic drugs...
  12. ncbi request reprint Stereotactic radiotherapy for ocular melanoma: initial experience using closed eyes for ocular target immobilization
    Raymond Miralbell
    Instituto Oncologico Teknon, Barcelona, Spain
    Technol Cancer Res Treat 6:413-7. 2007
    ..Margins of 3 mm around the target may be necessary to safely treat these tumors under ideal set-up conditions...
  13. ncbi request reprint Early improvements in vision after fractionated stereotactic radiotherapy for primary optic nerve sheath meningioma
    Brigitta G Baumert
    Radiation Oncology, University Hospital Zurich, Zurich, Switzerland
    Radiother Oncol 72:169-74. 2004
    ..To report on the efficacy and follow-up of 23 patients with primary optic nerve sheath meningioma (ONSM) with fractionated stereotactic conformal radiotherapy (SCRT)...